Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor

  • I. P. Gladysheva
  • , O. V. Polekhina
  • , T. A. Karmakova
  • , E. R. Nemtsova
  • , R. I. Yakubovskaya
  • , W. C. Shen
  • , A. R. Kennedy
  • , N. I. Larionova

Research output: Contribution to journalArticlepeer-review

Abstract

The present work reports the effect of conjugation of the anticarcinogenic and antitumor soybean Bowman-Birk protease inhibitor (BBI) with amphiphilic block copolymer of ethylene oxide and propylene oxide (PEO-PPO) as well as with monoclonal antibody via clinical dextran (D) on tumor-targeted delivery of BBI.

Original languageEnglish (US)
Pages (from-to)303-308
Number of pages6
JournalJournal of Controlled Release
Volume74
Issue number1-3
DOIs
StatePublished - Jul 6 2001
Externally publishedYes

Keywords

  • Ethylene oxide and propylene oxide block copolymer
  • Immunoconjugate
  • Soybean Bowman-Birk protease inhibitor (BBI)
  • Targeting
  • Tumor

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor'. Together they form a unique fingerprint.

Cite this